AVROBIO CEO Geoff MacKay resigns; CFO Erik Ostrowski named interim CEO

Tectonic Therapeutic, Inc.

CEO Geoff MacKay resigns effective May 1, 2023, to join an early-stage company; no disagreement with the company.
CFO Erik Ostrowski appointed President and Interim CEO, effective May 1, 2023; will continue as CFO.
Board of Directors begins search for a permanent CEO; Ostrowski has over 20 years of biotech finance experience.
MacKay served as founding CEO for eight years; company transitioning to late-stage development for Gaucher and cystinosis programs.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Erik Ostrowski

President and Interim Chief Executive Officer

TECX · Tectonic Therapeutic, Inc.

Effective: 2023-05-01
Filed: May 1, 2023, 7:59 PM ET

On April 28, 2023, the Board appointed Erik Ostrowski, the Company’s current Chief Financial Officer and Treasurer, as the Company’s President and Interim Chief Executive Officer, effective at 1:00 p.m. ET on May 1, 2023.

Departed

Geoff MacKay

President and Chief Executive Officer

TECX · Tectonic Therapeutic, Inc.

Effective: 2023-05-01
Successor: Erik Ostrowski
Filed: May 1, 2023, 7:59 PM ET

On April 28, 2023, Geoff MacKay provided notice of his resignation as President and Chief Executive Officer and a member of the Board of Directors (the “ Board ”) of AVROBIO, Inc. (the “ Company ”), effective at 1:00 p.m. ET on May 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Erik Ostrowski was appointed as President and Interim Chief Executive Officer at Tectonic Therapeutic, Inc..

Action: appointed
Role: President and Interim Chief Executive Officer

Exact text from the filing

On April 28, 2023, the Board appointed Erik Ostrowski, the Company’s current Chief Financial Officer and Treasurer, as the Company’s President and Interim Chief Executive Officer, effective at 1:00 p.m. ET on May 1, 2023.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Geoff MacKay resigned as President and Chief Executive Officer at Tectonic Therapeutic, Inc..

Action: resigned
Role: President and Chief Executive Officer

Exact text from the filing

On April 28, 2023, Geoff MacKay provided notice of his resignation as President and Chief Executive Officer and a member of the Board of Directors (the “ Board ”) of AVROBIO, Inc. (the “ Company ”), effective at 1:00 p.m. ET on May 1, 2023.

View on SEC.gov

Tectonic Therapeutic, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-23-021828

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.